On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Inks Prototype Deal, Secures Investment Funding

A leading importer of vehicles to Israel has signed with Foresight a non-binding MOU for the sale of the Eyes-On™ automotive vision system $12.4 million in private placement agreements signed with leading Israeli institutional investors Global advanced driver assistance system (ADAS) market expected to reach $67.43 billion by 2025, growing at 19 percent CAGR A […]

ChineseInvestors.com, Inc.’s (CIIX) NewCoins168.com Website Offers ‘Live VIP’ Courses Focused on Investing in Cryptocurrencies

Paid ‘VIP Service’ teaches cryptocurrency investing and trading, market trend analysis and trading tips for options as part of CIIX’s effort to instruct its Chinese-speaking audience NewCoins168.com site notes that CIIX expects to issue its own ICO in the second half of 2018 or 2019, creating an investment ‘ecosystem’ for audience CIIX offers a comprehensive […]

Marijuana Company of America, Inc. (MCOA) Launches CBD Infused Facial Moisturizer through hempSMART™ Subsidiary

MCOA focusing on non-psychoactive hemp cultivation and product markets Hemp industry’s predicted five-year CAGR of 25 percent expected to take it to $2.6 billion by 2022 hempSMART Face marks subsidiary’s extension into cosmetic products arena Progressive trends in the adoption of hemp-derived products continue to boost the prospects of Marijuana Company of America, Inc. (OTC: […]

Medical Cannabis Payment Solutions (REFG) Plans to Acquire Property and Register for Growing License in Vermont

Searching for property in Vermont to grow industrial hemp Acquired 40 acres of land in Utah, as well as SpeedyGrow and SpeedyVeg Continues to concentrate on core ‘Green’ platform Medical Cannabis Payment Solutions (OTC: REFG), a state-of-the-art financial services company targeting the cannabis industry, is expanding its footprint through acquisitions in Vermont, Utah and Colorado. […]

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Developing Passive Sensor Vision System Technology for Autonomous Vehicles

FRSX’s QuadSight™ multi-camera vision solution is a stereoscopic system that detects obstacles in all weather and lighting conditions designed for semi-autonomous and autonomous vehicles In its corporate presentation, FRSX cites projection of the autonomous self-driving vehicle market reaching $60 billion by 2030, from Mordor Intelligence LLP FRSX has in development its Eyes-On™ and Eye-Net™ patent-pending […]

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Floats on Rising Vaporizer Trends

Smoking as a delivery method faces increasing stigma Vaporization set to be a major smoking alternative Sunniva signs contract to supply extraction services to award winning cannabis brand Heightened awareness of the dangers posed by smoking is shaping the fast-developing cannabis marketplace. Smoking, the delivery vehicle of the tobacco industry, is playing a much lesser […]

 

From Our Blog

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

March 28, 2024

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron’s lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year. “In 2023 […]

Rotate your device 90° to view site.